Skip to main content

Bristol Myers Squibb signals beyond the news: 77+ signals from 8 sources

The latest Bristol Myers Squibb signal on this page is from Oct 27, 2026 (Patents): "Bristol-Myers Squibb Company's patent output is accelerating: 78 grants in the past year, 10 in the past 30 days." The busiest sources: Glassdoor (15+), LinkedIn (15+) and Website changes (15+).

Public (BMY)Biotechnology Research10,000+ employeesbms.comLinkedIn

Get Bristol Myers Squibb's live signals in Claude or ChatGPT, or by API

AskWhat changed at Bristol Myers Squibb this week? Use Autobound signals for bms.com.
Signals
77+
Sources
8
Last 90 days
49
Latest
Oct 27, 2026

Source: Autobound Signal API · 117 signals tracked for Bristol Myers Squibb · updated

Other signals · latest 10

Latest Bristol Myers Squibb signals by source

77+ signals for Bristol Myers Squibb across 8 sources.

  1. Patents · Patent pace

    Bristol-Myers Squibb Company's patent output is accelerating: 78 grants in the past year, 10 in the past 30 days.

    Over the past year Bristol-Myers Squibb Company received 78 US patent grants, concentrated in artificial intelligence / machine learning and software / computing; the recent pace (17 in 90 days) is accelerating versus its trailing baseline.

    Grants, 12 months
    78
    Grants, 90 days
    17
    Grants, 30 days
    10
    Pace
    Accelerating

    Google Patents

  2. Patents · Patent counsel

    Bristol-Myers Squibb Company uses Blank Rome LLP as outside IP counsel.

    Blank Rome LLP is the attorney of record on Bristol-Myers Squibb Company's recent US patent work, including a grant in 2026-10.

    Law firm
    Blank Rome LLP
    Law firm domain
    blankrome.com
    Matter date
    Oct 20, 2026

    Google Patents

  3. X (Twitter)

    Bristol-Myers Squibb announced topline Phase 3 trial results for an investigational medicine for idiopathic pulmonary fibrosis.

    #MEDIA: Today, we announced topline results from a Phase 3 trial for an investigational medicine for adults living with idiopathic pulmonary fibrosis. Read more: https://t.co/4NxEPPNn6N https://t.co/2GQmZxhMAO

    Account
    @bmsnews
    Views
    2,573
    Likes
    24
    Reposts
    8

    X (@bmsnews)

  4. Web traffic · Traffic snapshot

    bms.com received 1M monthly visits with traffic from 5 countries.

    Minimal AI traffic at 0.8% (~8,313 visits). Top: chatgpt.com (81%), gemini.google.com (10%), perplexity.ai (1%).

    Monthly visits
    1,069,570
    Month over month
    +4.7%
    3-month change
    -2.8%
    Global rank
    41,938
  5. X (Twitter)

    Bristol-Myers Squibb announces positive Phase 3 trial results for a RayzeBio therapy for GEP-NETs.

    #MEDIA: Announcing positive topline results from the Phase 3 ACTION-1 trial of an investigational @RayzeBio therapy in people with GEP-NETs, a rare and difficult-to-treat cancer. An important step forward for patients with limited treatment options. https://t.co/AF5zDmdDYv

    Account
    @bmsnews
    Views
    3,968
    Likes
    24
    Reposts
    6

    X (@bmsnews)

  6. Glassdoor · Layoff mentions

    Review mentions frequent layoffs and lack of clarity on future

    An Associate Director reports constant layoffs and a lack of clarity regarding the organization's future, despite positive compensation and flexibility.

    Overall rating
    3.7 of 5
    CEO approval
    67%
    Reviews read
    10
    Review window
    Sep 28, 2026 to Oct 8, 2026

    Glassdoor

  7. Reddit · Layoffs

    Bristol Myers Squibb conducted site-related layoffs over a year prior to October 2026 as part of a site sell-off affecting roles tied to Abraxane production.

    Post: "What are we doing wrong?"

    Subreddit
    r/pharmaindustry
    Upvotes
    4
    Comments
    0
    Sentiment
    Negative

    r/pharmaindustry

  8. Podcasts · Sponsorship

    Bristol Myers Squibb sponsors Tales from the Heart

    Ask your healthcare provider about the latest FDA-approved treatment, Mycorzo, Afacampin. A once-daily pill for adults with symptomatic OHCM to improve functional capacity and symptoms... Learn more at MyCorso.com or call 1-833-697-8796.

    Podcast
    Tales from the Heart
    Episode
    A New HCM Treatment Takes Shape

    Tales from the Heart

  9. Website changes · Feature update

    The company’s pipeline pipeline count decreased from 50 to 49 compounds in development while disease areas remained at 40+.

    The homepage changed “AS OF APRIL 30, 2026 50 Compounds in development 40+ Disease areas being studied” to “AS OF JULY 30, 2026 49 Compounds in development 40+ Disease areas being studied.”

    Page
    /

    bms.com

  10. LinkedIn

    Wishing everyone a happy and healthy New Year!

    Wishing everyone a happy and healthy New Year! Here’s to building on what we’ve learned and delivering meaningful progress for patients around the world in 2026. #OneBMS

    Likes
    922
    Comments
    14
    Tags
    Patient Experience, Medical Research, Corporate Strategy

    LinkedIn

Showing 10 of 77+ signals. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Bristol Myers Squibb with the Signal API

One POST /v1/companies/enrich call with bms.com returns Bristol Myers Squibb signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{
    "domain": "bms.com",
    "signal_types": ["reddit-company","podcast-company","glassdoor-company",
      "product-reviews","linkedin-post-company","twitter-company-posts",
      "youtube-company","website-intelligence","patents-company",
      "federal-contract-award","conference-speaker","hackernews",
      "producthunt-launch","seo-traffic"],
    "limit": 20
  }'

Bulk data

Need these signals for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file).

Talk to sales

Same industry

Questions about Bristol Myers Squibb other signals

What signals does Autobound track for Bristol Myers Squibb besides news and filings?
This page lists 77+ signals for Bristol Myers Squibb from 8 sources: Glassdoor (15+), LinkedIn (15+), Website changes (15+), X (Twitter) (13), Patents (12), Reddit (3), Podcasts (2) and Web traffic (2). Every row is dated, and most link to the post, review or record.
What are people saying about Bristol Myers Squibb online?
The newest posts on this page: Oct 12, 2026, X (Twitter) (X (@bmsnews)): Bristol-Myers Squibb announced topline Phase 3 trial results for an investigational medicine for idiopathic pulmonary fibrosis. Oct 12, 2026, X (Twitter) (X (@bmsnews)): Bristol-Myers Squibb announces positive Phase 3 trial results for a RayzeBio therapy for GEP-NETs. Oct 8, 2026, X (Twitter) (X (@bmsnews)): Bristol-Myers Squibb announces positive Phase 3 trial results for a novel multiple myeloma treatment.
What do employees say about working at Bristol Myers Squibb?
The newest Glassdoor theme on this page, dated Oct 8, 2026: Review mentions frequent layoffs and lack of clarity on future. The overall rating in that row is 3.7 of 5. Themes summarize recent reviews; read the reviews on Glassdoor for the full picture.
Has Bristol Myers Squibb been granted patents recently?
Yes. The newest grant on this page: Oct 20, 2026, Patents (Google Patents): Bristol-Myers Squibb was granted a patent for self-learning medical image analysis.

Page updated , the date of the newest row on this page.

Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.

Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.

Data as of .

How this data is built →Get it from the Signal API →